Automated and Rapid Microbiological Tests

Automated and Rapid Microbiological Tests

Global Automated and Rapid Microbiological Tests Market to Reach $8.1 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Automated and Rapid Microbiological Tests estimated at US$5.3 Billion in the year 2020, is projected to reach a revised size of US$8.1 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027. GC/CRT (Clinical), one of the segments analyzed in the report, is projected to record a 7.4% CAGR and reach US$1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Aiss (clinical) segment is readjusted to a revised 3.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2 Billion, While China is Forecast to Grow at 8.6% CAGR
The Automated and Rapid Microbiological Tests market in the U.S. is estimated at US$2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$766.1 Million by the year 2027 trailing a CAGR of 8.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 5.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$561.4 Million by the year 2027.

ABCS (Clinical) Segment to Record 3.1% CAGR
In the global ABCS (Clinical) segment, USA, Canada, Japan, China and Europe will drive the 3.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$372.2 Million in the year 2020 will reach a projected size of US$456.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 3.8% CAGR through the analysis period.

Select Competitors (Total 77 Featured) -

  • Abbott Laboratories
  • Abbott Molecular, Inc.
  • Aidian Oy
  • Beckman Coulter, Inc.
  • Becton Dickinson and Company
  • bioMérieux SA
  • bioMerieux, Inc.
  • Bio-Rad Laboratories, Inc
  • Cellabs Pty Ltd
  • Cepheid Inc.
  • CorisBioconcept SPRL
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • MedMira Inc.
  • Meridian Bioscience, Inc.
  • OraSure Technologies, Inc.
  • Oxoid Limited
  • QIAGEN N.V.
  • Quidel Corporation
  • Rapid Micro Biosystems, Inc.
  • Sekisui Diagnostics, LLC
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of COVID-19 Pandemic and Looming Global Recession
Clinical Microbiology Gains Prominence as Scientists Mobilize United Efforts to Find Ways to Detect, Treat & Vaccinate People Against the Novel Coronavirus: COVID-19 Tests Per Million Population by Country (As of 15 June 2021)
A New, 20-Minute Assay for COVID-19 Diagnosis
Automated and Rapid Microbiological Tests – Global Key Competitors Percentage Market Share in 2022 (E)
Automated and Rapid Microbiological Tests: An Introduction
Enabling Technologies of Automated & Rapid Microbiological Tests
Clinical Applications of Automated & Rapid Microbiological Tests
Applications in Non-Clinical Investigations
Global Market Prospects & Outlook
Evolutionary Battle against Microbes Drives Market Future
Clinical Applications Lead the Global Market for Automated and Rapid Microbiological Testing
Developed Regions Lead, Developing Economies to Boost Future Growth
Competition
Recent Market Activity
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rapid Diagnostics Bring in a Transformation to Clinical Testing Practices
Traditional Rapid Microbiological Tests Make Way for New, Probe Tests
Lab Automation Trend Augurs Well for Microbiological Testing Labs
Traditional Approaches Give Way to Modern Automated Microbiology Systems
Microbiology Laboratories Switch to Automation to Push Yields
Growing Incidence of Infectious Diseases to Fuel Demand for Rapid Microbiology Testing
Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
Rising Prevalence of Respiratory Infections Drive Market Growth
Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
Rise in Prevalence of COPD Augments Demand
Global Prevalence of COPD: Percentage of Men and Women Affected by Age Group
Influenza Boosts Rapid Test Prospects
Flu Related CDC Estimates from October 2019-April 2020
Rise in Pollution Levels Trigger Increase in Respiratory Diseases, Driving Opportunities for Automated Microbiology Tests
Percentage Share Breakdown of Global Deaths Linked to Air Pollution
Most Polluted Countries Worldwide: Average PM2.5 concentration (μg/m³) for 2020
Sustained Threat of HIV and Sexually Transmitted Diseases Amplify Need for Rapid Microbiological Testing
Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2020
Number of AIDS-Related Deaths (in Thousands) by Region for 2018
Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
Home HIV Testing Emerges as a Lucrative Option
Advancements in Molecular Diagnostics Drive Market Growth
Emerging Technologies in Clinical Microbiology Diagnostics Aim at Faster Diagnosis
Automated Blood Culture Systems: The Gold Standard in the Fight against Bacteremia
Advancements in Molecular Diagnostics: A Boon for Rapid Microbiological Testing Market
Biotechnology: A Crucial Step Ahead in the Growing Popularity of Rapid Microbial Tests
Healthcare Needs of the World’s Aging Population: Potential Opportunity in Store
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Increase in Healthcare Spending in Emerging Markets to Propel Demand for Automated Microbiological Testing
World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Elderly Healthcare Expenditure as a % of GDP for 1970, 2010 and 2050
Clinical Microbiology Market Benefits from Digitalization and Robotization Trend
Integration of Clinical Microbiology with Cloud Computing
Artificial Intelligence Holds Positive Implications for Automation of Clinical Microbiology
Point-of-Care Rapid Microbiological Testing: Yet to Realize Its Full Potential…
Technological Advancements to Drive the Automated Microbiology Testing Market
Focus on Safe and High-Quality Foods Propels Rapid Microbiological Testing
Number of Food Allergen Recalls in the US: Breakdown by FDA-Regulated Foods and FSIS-Regulated Foods for 2019
Foodborne Illness Outbreak Investigations in the US (2019 & 2020)
Impact of COVID-19 on Food Safety Testing Industry
Stringent Norms Necessitate Food Safety Testing
Food Microbiology Testing Market on a Growth Spree
Global Food Safety Testing Market Breakdown (in %) by Segment for 2020
Rapid and Automated Tests Emerge as an Attractive Solution
Leading Food Processors Exhibit Inclination Towards Rapid Microbiological Testing
Automation of Food Microbiology Labs
Poultry Industry Embraces Rapid Microbiological Testing Technologies
Rapid Microbial Testing in Dairy Industry
Real-time PCR/qPCR Technologies Fundamental in Food Safety Testing
Technical and Cost Related Hurdles Hamper the Microbiology Testing Market
Rapid Microbiological Testing Gains Significance in the Pharmaceutical Industry
Key Advantages of Rapid Microbiological Tests for Pharmaceutical Industry
Growing Importance of Rapid Microbiological Testing for Pharma Laboratories
Key RMM Technologies for Pharmaceutical Industry
Adoption of Rapid Methods for QC Microbiology in Biopharmaceuticals
Advancements in Rapid Microbiological Testing for Pharmaceutical Industry
Rapid Microbial Testing for Regenerative Medicine: An Emerging Space
Rapid Microbiological Methods and the Regulatory Environment in Drug Development Industry
FDA’s Requirements for Validation of RMM
EMA’s Guidance on Use of RMMs for Water Testing
Rapid Microbial Testing Emerges as an Important Means for Quality Control of Advanced Therapies
Antibiotic Resistant Bacteria Throws the Spotlight on Rapid Microbial Testing Tools
Antimicrobial Vulnerability Testing and Identification of Microbial strains
Role of Microscopy in Antimicrobial Susceptibility Testing
Rising Prominence of NAAT-Driven AST
Economic Factors Promise Growth for Rapid AST
Rapid Technologies Gain Momentum in Environment Testing Field
Deteriorating Quality of Water Throws Emphasis on Water Testing Services
Percentage of Contaminated Water in Drinking Water Supplies in Africa, Asia, and Latin America and Caribbean
Key Issues Confronting the Rapid Microbiological Tests Market
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for GC/CRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for GC/CRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for GC/CRT (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for AISS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for AISS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for AISS (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for ABCS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for ABCS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for ABCS (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for SIRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for SIRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for SIRT (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for ATS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for ATS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for ATS (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 19: World Recent Past, Current & Future Analysis for Other Applications (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Other Applications (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Other Applications (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 22: World Recent Past, Current & Future Analysis for Non-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Non-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Non-Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
Rising Threat of Infectious Diseases Drive Significance of Rapid Microbiological Testing
Healthcare Spending as a % of GDP in the US: 2010-2020
COVID-19 Pandemic: US Emerges as a Major Market for COVID-19 Tests
US-based Labs Ramp Up Operations Amidst the COVID-19 Situation
Unmet Diagnostic Needs of Aging Population: Major Driver
US Elderly Population: Expected Growth Rates Over the Years 2005-2025
North American Aging Population by Age Group: 1975-2050
Select Product Categories in Rapid Microbiological Testing – An Overview
Automated Susceptibility Testing Systems
STD Rapid Tests
Respiratory Rapid Tests
Streptococcus Infection Rapid Tests
Food Safety Microbiological Testing Market: Concerns over Food Safety Drive Market Gains
Foodborne Illnesses, Hospitalizations and Deaths in the US: Percentage Breakdown for Known Pathogens and Unspecified Agents
Leading Pathogens Causing Foodborne Illnesses in the US: Percentage Breakdown of Number of Illnesses by Known Pathogens
Number of Food Recalls in the US: Breakdown by Class I Recalls and Class II & III Recalls for 2014-2019
TABLE 25: USA Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 26: USA Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 27: USA 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
CANADA
TABLE 28: Canada Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 29: Canada Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 30: Canada 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
JAPAN
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Market Overview
Breakdown of Population by Age Group in Japan: 2010, 2020, and 2025
COVID-19 Testing Market In Japan
TABLE 31: Japan Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 32: Japan Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 33: Japan 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
CHINA
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
Market Overview
COVID-19 Testing Market
TABLE 34: China Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 35: China Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 36: China 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
EUROPE
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
COVID-19 Pandemic Propels Demand for Rapid Microbiological Testing
Growth in Clinical Diagnostics Automation
Rise in Automated and Rapid Tests in Clinical Applications
Aging Demography: An Opportunity Indicator
Food Safety Testing Market in Europe: An Overview
TABLE 37: Europe Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 38: Europe Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 39: Europe 15-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
TABLE 40: Europe Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 41: Europe Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 42: Europe 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
FRANCE
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 43: France Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 44: France Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 45: France 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
GERMANY
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 46: Germany Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 47: Germany Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 48: Germany 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
ITALY
TABLE 49: Italy Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 50: Italy Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 51: Italy 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
UNITED KINGDOM
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 52: UK Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 53: UK Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 54: UK 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
SPAIN
TABLE 55: Spain Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 56: Spain Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 57: Spain 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
RUSSIA
TABLE 58: Russia Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: Russia Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 60: Russia 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 61: Rest of Europe Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 62: Rest of Europe Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 63: Rest of Europe 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Market Overview
TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 65: Asia-Pacific Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 66: Asia-Pacific 15-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
TABLE 67: Asia-Pacific Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 68: Asia-Pacific Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 69: Asia-Pacific 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
AUSTRALIA
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
TABLE 70: Australia Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: Australia Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 72: Australia 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
INDIA
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
Market Overview
Demand for Automated and Rapid Microbiology Testing Poised for Growth
Automation – Name of the Game
Private Enterprises Encourage Changes in Diagnostics Sector
TABLE 73: India Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 74: India Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 75: India 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
SOUTH KOREA
TABLE 76: South Korea Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 77: South Korea Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 78: South Korea 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
TABLE 79: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 80: Rest of Asia-Pacific Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 81: Rest of Asia-Pacific 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
LATIN AMERICA
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
TABLE 82: Latin America Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 83: Latin America Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 84: Latin America 15-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
TABLE 85: Latin America Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 86: Latin America Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 87: Latin America 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
ARGENTINA
TABLE 88: Argentina Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: Argentina Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 90: Argentina 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
BRAZIL
TABLE 91: Brazil Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 92: Brazil Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 93: Brazil 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
MEXICO
TABLE 94: Mexico Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: Mexico Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 96: Mexico 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
REST OF LATIN AMERICA
TABLE 97: Rest of Latin America Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 98: Rest of Latin America Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 99: Rest of Latin America 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
MIDDLE EAST
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
TABLE 100: Middle East Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 101: Middle East Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 102: Middle East 15-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
TABLE 103: Middle East Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 104: Middle East Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 105: Middle East 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
IRAN
TABLE 106: Iran Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 107: Iran Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 108: Iran 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
ISRAEL
TABLE 109: Israel Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 110: Israel Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 111: Israel 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
SAUDI ARABIA
TABLE 112: Saudi Arabia Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 113: Saudi Arabia Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 114: Saudi Arabia 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
UNITED ARAB EMIRATES
TABLE 115: UAE Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 116: UAE Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 117: UAE 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
REST OF MIDDLE EAST
TABLE 118: Rest of Middle East Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 119: Rest of Middle East Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 120: Rest of Middle East 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
AFRICA
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
TABLE 121: Africa Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 122: Africa Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 123: Africa 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2021 & 2027
IV. COMPETITION
Total Companies Profiled: 77

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings